GeneReach Biotechnology Corp. (TPEX:4171)
Taiwan · Delayed Price · Currency is TWD 17.35
-0.20 (-1.14%)
Aug 26, 2026, 1:30 PM CST
GeneReach Biotechnology Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 151.33 | 155.07 | 110.27 | 216.77 | 748.61 | 663.43 |
Short-Term Investments | 225.23 | 114 | 181.01 | 285.95 | - | - |
Trading Asset Securities | 19.26 | 20.69 | 122.7 | - | - | - |
Cash & Short-Term Investments | 395.82 | 289.76 | 413.98 | 502.72 | 748.61 | 663.43 |
Cash Growth | 89.99% | -30.01% | -17.65% | -32.85% | 12.84% | 111.50% |
Accounts Receivable | 32.28 | 39.37 | 43.05 | 21.47 | 55.86 | 195.75 |
Other Receivables | 1.85 | 2.16 | 3.37 | 1.68 | 0.4 | 0.72 |
Receivables | 34.13 | 41.53 | 46.42 | 23.14 | 56.26 | 196.47 |
Inventory | 41.77 | 32.56 | 37.52 | 67.37 | 235.81 | 268.3 |
Prepaid Expenses | 3.79 | 1.88 | 3.24 | 5.88 | 8.36 | 34.68 |
Other Current Assets | 3.7 | 118.43 | 93.51 | 33.01 | 21.03 | 17.66 |
Total Current Assets | 479.21 | 484.16 | 594.67 | 632.14 | 1,070 | 1,181 |
Property, Plant & Equipment | 260.74 | 284.73 | 359.65 | 433.83 | 436.93 | 397.11 |
Long-Term Investments | 3.24 | - | - | - | - | 3.24 |
Other Intangible Assets | 14.42 | 15.43 | 12.4 | 12.35 | 9.49 | 10.03 |
Long-Term Deferred Tax Assets | 82.08 | 81.78 | 83.21 | 77.65 | 35.26 | 24 |
Other Long-Term Assets | 18.43 | 14.95 | 16.56 | 20.18 | 70.15 | 69.51 |
Total Assets | 858.12 | 881.05 | 1,066 | 1,176 | 1,622 | 1,684 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 10.34 | 7.19 | 7.74 | 8.86 | 13.35 | 31.68 |
Short-Term Debt | 136.09 | 136 | 171 | 104 | 49 | 49 |
Current Portion of Long-Term Debt | - | - | - | 35.62 | 204.42 | 7.5 |
Current Portion of Leases | 11.43 | 11.4 | 11.64 | 11.38 | 12.64 | 8.54 |
Current Income Taxes Payable | - | - | 7 | 3.59 | 23.08 | 74.45 |
Current Unearned Revenue | 4.91 | 3.34 | 2.93 | 4.96 | 7.8 | 19.43 |
Other Current Liabilities | 36.13 | 43.2 | 39.21 | 37.5 | 74.8 | 87.62 |
Total Current Liabilities | 198.91 | 201.13 | 239.53 | 205.9 | 385.09 | 278.21 |
Long-Term Debt | - | - | - | - | 15 | 217.39 |
Long-Term Leases | 65.83 | 71.7 | 84.59 | 97.74 | 108.89 | 87.35 |
Long-Term Unearned Revenue | 9.87 | 9.53 | 10.57 | 8.78 | 8.95 | 8.82 |
Pension & Post-Retirement Benefits | - | - | - | - | - | 1.73 |
Long-Term Deferred Tax Liabilities | 2.04 | 1.99 | 6.29 | 1.26 | 1.28 | 1.2 |
Other Long-Term Liabilities | - | - | 0.02 | 0.02 | 0.02 | 1.64 |
Total Liabilities | 276.64 | 284.34 | 341 | 313.71 | 519.23 | 596.35 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 580.58 | 580.58 | 574.58 | 574.58 | 459.66 | 417.87 |
Additional Paid-In Capital | 150.54 | 150.54 | 144.9 | 144.9 | 144.9 | 144.9 |
Retained Earnings | -126.58 | -117.32 | -3.29 | 114.74 | 464.44 | 491.74 |
Treasury Stock | -25.73 | -17.31 | - | - | - | - |
Comprehensive Income & Other | -6.1 | -9.76 | 0.79 | -2.15 | -1.33 | -4.7 |
Total Common Equity | 572.7 | 586.73 | 716.98 | 832.06 | 1,068 | 1,050 |
Minority Interest | 8.78 | 9.99 | 8.51 | 30.37 | 35.01 | 38.26 |
Shareholders' Equity | 581.48 | 596.72 | 725.49 | 862.44 | 1,103 | 1,088 |
Total Liabilities & Equity | 858.12 | 881.05 | 1,066 | 1,176 | 1,622 | 1,684 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 213.34 | 219.1 | 267.23 | 248.74 | 389.95 | 369.78 |
Net Cash (Debt) | 182.48 | 70.67 | 146.75 | 253.98 | 358.66 | 293.65 |
Net Cash Growth | - | -51.84% | -42.22% | -29.19% | 22.14% | 133.48% |
Net Cash Per Share | 3.19 | 1.24 | 2.55 | 4.42 | 6.05 | 5.01 |
Filing Date Shares Outstanding | 55.44 | 57.3 | 57.46 | 57.46 | 57.46 | 57.46 |
Total Common Shares Outstanding | 55.44 | 57.3 | 57.46 | 57.46 | 57.46 | 57.46 |
Working Capital | 280.3 | 283.03 | 355.14 | 426.24 | 684.99 | 902.32 |
Book Value Per Share | 10.33 | 10.24 | 12.48 | 14.48 | 18.58 | 18.27 |
Tangible Book Value | 558.28 | 571.29 | 704.59 | 819.72 | 1,058 | 1,040 |
Tangible Book Value Per Share | 10.07 | 9.97 | 12.26 | 14.27 | 18.42 | 18.10 |
Buildings | - | 296.08 | 293.85 | 292.04 | 267.33 | 266.03 |
Machinery | - | 306.55 | 332.71 | 309.58 | 273.19 | 231.16 |
Construction In Progress | - | 0.26 | - | - | 20.95 | - |